Expertise in
3
conditions

Annie Derlon-Borel

Caen, FR 
Expertise in
3
conditions
Caen, FR 

Overview

Annie Derlon-Borel practices practicing medicine in Caen, France.

Ms. Derlon-Borel is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Von Willebrand Disease (VWD), Blood Clots, Hemophilia A, and Hemophilia B.

She is actively involved in clinical research, co-authoring 28 peer reviewed articles and participating in 3 clinical trials.

Gender

Female

Locations

Caen, France
Other Locations
Montpellier, France
Rouen, France
Lille, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3, Prospective, Multicenter, Uncontrolled, Open-Label Clinical Study to Determine the Efficacy, Safety, and Tolerability of rVWF With or Without ADVATE in the Treatment and Control of Bleeding Episodes, the Efficacy and Safety of rVWF in Elective and Emergency Surgeries, and the Pharmacokinetics (PK) of rVWF in Children Diagnosed With Severe Von Willebrand Disease
A Phase 3, Prospective, Multicenter, Uncontrolled, Open-Label Clinical Study to Determine the Efficacy, Safety, and Tolerability of rVWF With or Without ADVATE in the Treatment and Control of Bleeding Episodes, the Efficacy and Safety of rVWF in Elective and Emergency Surgeries, and the Pharmacokinetics (PK) of rVWF in Children Diagnosed With Severe Von Willebrand Disease
Enrollment Status: Completed
Publish Date: May 15, 2026
Intervention Type: Biological
Study Drugs: Von Willebrand Factor, Factor VIII
Study Phase: Phase 3
Phase 3, Prospective, Multi-center, Open Label Study to Investigate Safety, Immunogenicity and Hemostatic Efficacy of PEGylated Factor VIII (BAX 855) in Previously Untreated Patients (PUPs) < 6 Years With Severe Hemophilia A (FVIII < 1%)
Phase 3, Prospective, Multi-center, Open Label Study to Investigate Safety, Immunogenicity and Hemostatic Efficacy of PEGylated Factor VIII (BAX 855) in Previously Untreated Patients (PUPs) < 6 Years With Severe Hemophilia A (FVIII < 1%)
Enrollment Status: Completed
Publish Date: July 28, 2025
Intervention Type: Biological
Study Drugs: PEG-Factor VIII, Eloctate ITI
Study Phase: Phase 3
Determinants and Consequences of the Transition to Adulthood Among Adolescents With Haemophilia - TRANSHEMO
Determinants and Consequences of the Transition to Adulthood Among Adolescents With Haemophilia - TRANSHEMO
Enrollment Status: Completed
Publish Date: February 14, 2023
Intervention Type: Other
View 2 Less Clinical Trials

28 Total Publications

Health-related quality of life in adults with von Willebrand disease: results of the French real-life Willebrand study on health-related quality of life.
Health-related quality of life in adults with von Willebrand disease: results of the French real-life Willebrand study on health-related quality of life.
Journal: Research and practice in thrombosis and haemostasis
Published: December 12, 2025

Frequently Asked Questions about Annie Derlon-Borel

Is Annie Derlon-Borel a top-rated expert for Von Willebrand Disease (VWD)?

MediFind is an objective health platform that identifies experts based on real-world data. Annie Derlon-Borel is classified as an Elite expert for Von Willebrand Disease (VWD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Annie Derlon-Borel participate in research or clinical trials?

Yes. Annie Derlon-Borel has published 28 articles and abstracts on conditions like Von Willebrand Disease (VWD). You can view a list of Annie Derlon-Borel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Derlon-Borel's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile